II-VI Incorporated Reports Fiscal 2017 Fourth Quarter and Full Year Earnings
Aug 07, 2017 10:55 am UTC| Business
Record Fourth Quarter and Full Year RevenueRecord Full Year Bookings Exceed $1.0 Billion PITTSBURGH, Aug. 07, 2017 -- II-VI Incorporated (Nasdaq:IIVI) ("II-VI" or the "Company") today reported results for its fiscal...
Coolisys Technologies Announces Acquisition of Power-Plus Technical Distributors
Aug 07, 2017 10:50 am UTC| Business
FREMONT, Calif., Aug. 07, 2017 -- Digital Power Corporation (NYSE MKT:DPW) ("Digital Power" or the "Company"), a company seeking to increase revenues through acquisitions and organic growth, today announced that its...
II-VI Incorporated Acquires Kaiam’s 6-inch Wafer Fabrication Facility in the U.K.
Aug 07, 2017 10:50 am UTC| Business
300,000 square foot facility with a 100,000 square foot clean room near Newcastle, U.K.GaAs, SiC and InP devices capabilitiesPurchase price of the acquisition was $80 million in cash PITTSBURGH, Aug. 07,...
CONE Midstream Reports Second Quarter Results
Aug 07, 2017 10:45 am UTC| Business
CANONSBURG, Pa., Aug. 07, 2017 -- CONE Midstream Partners LP (NYSE:CNNX) ("CONE Midstream" or the "Partnership") today reported financial and operational results for the three months ended June 30, 2017(1). Second...
Aug 07, 2017 10:45 am UTC| Business
DEVON, Pa., Aug. 07, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal pharmaceutically-produced...
Crown Crafts Transforms Its Online Business with Acquisition of Internet Retailer, Carousel Designs
Aug 07, 2017 10:45 am UTC| Business
GONZALES, La., Aug. 07, 2017 -- Crown Crafts, Inc. (NASDAQ:CRWS) (“Crown Crafts” or the “Company”) today announced that it has acquired the assets and business of Carousel Designs, LLC, based in Douglasville, Georgia,...
Aug 07, 2017 10:30 am UTC| Business
BEVERLY, Mass., Aug. 07, 2017 -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces that it has completed patient enrollment for its ongoing Phase...